Michael L. Steinberg

8.4k total citations · 3 hit papers
273 papers, 4.4k citations indexed

About

Michael L. Steinberg is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael L. Steinberg has authored 273 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Pulmonary and Respiratory Medicine, 123 papers in Radiation and 89 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael L. Steinberg's work include Advanced Radiotherapy Techniques (123 papers), Prostate Cancer Diagnosis and Treatment (108 papers) and Prostate Cancer Treatment and Research (92 papers). Michael L. Steinberg is often cited by papers focused on Advanced Radiotherapy Techniques (123 papers), Prostate Cancer Diagnosis and Treatment (108 papers) and Prostate Cancer Treatment and Research (92 papers). Michael L. Steinberg collaborates with scholars based in United States, Canada and Australia. Michael L. Steinberg's co-authors include Patrick A. Kupelian, Minsong Cao, Pin‐Chieh Wang, Amar U. Kishan, Daniel A. Low, Percy Lee, Christopher R. King, James Lamb, Ann C. Raldow and Mitchell Kamrava and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael L. Steinberg

250 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

2013 334 citations Christopher R. King, Donald B. Fuller et al. profile →
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study

2017 226 citations Allen M. Chen, Carol Felix et al. profile →
Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate Cancer

2023 148 citations Amar U. Kishan, James Lamb et al. profile →

Peers

Countries citing papers authored by Michael L. Steinberg

Since Specialization

Citations

This map shows the geographic impact of Michael L. Steinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Steinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Steinberg more than expected).

Fields of papers citing papers by Michael L. Steinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Steinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Steinberg. The network helps show where Michael L. Steinberg may publish in the future.

Co-authorship network of co-authors of Michael L. Steinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Steinberg. A scholar is included among the top collaborators of Michael L. Steinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Steinberg. Michael L. Steinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing Prostate Cancer Treatment: A Review of CT and MR-Guided Online Adaptive Radiotherapy Techniques 2025 ·Seminars in Radiation Oncology ·Javier Casillas, Luca Valle, (unknown), D O’Connell, X. Sharon Qi, James Lamb, (unknown), Michael L. Steinberg, Minsong Cao, Amar U. Kishan	0
2	Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial) 2024 ·Journal of Nuclear Medicine ·(unknown), (unknown), (unknown), Wolfgang P. Fendler, Matthias Eiber, Boris Hadaschik, (unknown), Nader Hirmas, (unknown), Martin Stuschke, Johannes Czernin, Michael L. Steinberg, Nicholas G. Nickols, Amar U. Kishan, Jérémie Calais	5
3	Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer 2024 ·Journal of Nuclear Medicine ·(unknown), Angela C. Rieger, Andrea Farolfi, (unknown), Amar U. Kishan, Nicholas G. Nickols, Michael L. Steinberg, Luca Valle, Matthew B. Rettig, Johannes Czernin, Jérémie Calais	6
4	A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Ricky R. Savjani, Nicholas Jackson, Jie Deng, (unknown), (unknown), Brian E. Kadera, Joseph G. Crompton, Lucas M. Wessel, Bartosz Chmielowski, Arun S. Singh, Scott D. Nelson, Sarah Dry, Joanne B. Weidhaas, Michael L. Steinberg, Nicholas M. Bernthal, Frederick C. Eilber, Anusha Kalbasi, Vishruth K. Reddy	1
5	Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial 2024 ·European Urology ·(unknown), Matthew B. Rettig, John Shen, Robert E. Reiter, Alan Lee, Michael L. Steinberg, Luca Valle, (unknown), Tahmineh Romero, Jérémie Calais, Johannes Czernin, Nicholas G. Nickols, Amar U. Kishan	10
6	The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma 2023 ·Cancer Reports ·(unknown), (unknown), Narek Shaverdian, Percy P. Lee, Phillip Beron, Michael L. Steinberg, Ann C. Raldow	2
7	Patient-Reported Urinary and Bowel Quality of Life Outcomes Following External Beam Radiotherapy with or without High-Dose-Rate Brachytherapy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR) 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Wee Loon Ong, (unknown), David Joseph, Allison Steigler, James W. Denham, Jeremy Millar, Luca Valle, Michael L. Steinberg, Tonghui Ma, Albert J. Chang, Nicholas G. Zaorsky, Daniel E. Spratt, Tahmineh Romero, Amar U. Kishan	1
8	MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations 2023 ·Seminars in Radiation Oncology ·P.T. Courtney, Luca Valle, Ann C. Raldow, Michael L. Steinberg	1
9	Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT 2022 ·Prostate Cancer and Prostatic Diseases ·(unknown), Tahmineh Romero, (unknown), Matthew B. Rettig, Michael L. Steinberg, Amar U. Kishan, Dörthe Schaue, Robert E. Reiter, Beatrice S. Knudsen, Nicholas G. Nickols	10
10	A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma 2020 ·Clinical Cancer Research ·Anusha Kalbasi, Mitchell Kamrava, Fang‐I Chu, Donatello Telesca, (unknown), Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah Dry, Jackie Hernandez, Bartosz Chmielowski, Arun S. Singh, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Joanne B. Weidhaas, Fritz C. Eilber	77
11	Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs 2020 ·Physics in Medicine and Biology ·Yu Gao, Anusha Kalbasi, William Hsu, Dan Ruan, Jie Fu, Jiaxin Shao, Minsong Cao, Chenyang Wang, Fritz C. Eilber, Nicholas M. Bernthal, Susan V. Bukata, Sarah Dry, Scott D. Nelson, Mitchell Kamrava, John H. Lewis, Daniel A. Low, Michael L. Steinberg, Peng Hu, Yingli Yang	43
12	MicroRNA-based Biomarkers predicting Long-Term Toxicity to Prostate SBRT 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Amar U. Kishan, Dan Ruan, (unknown), (unknown), Michael L. Steinberg, (unknown)	2
13	Patient perspectives and treatment regret after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal cancer: Findings from a phase II trial 2019 ·Head & Neck ·Narek Shaverdian, John V. Hegde, Carol Felix, Sophia Hsu, Vincent Basehart, Michael L. Steinberg, Allen M. Chen	8
14	Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Amar U. Kishan, Aaron E. Katz, C.A. Mantz, (unknown), Limor Appelbaum, D.A. Loblaw, I.D. Kaplan, Huong Pham, Mark K. Buyyounouski, Donald B. Fuller, R. Meier, Sean P. Collins, Narek Shaverdian, (unknown), Yongyi Yuan, H.P. Bagshaw, Nicolas D. Prionas, Nicholas G. Nickols, Michael L. Steinberg, (unknown)	2
15	The Patient's Perspective on Breast Radiation Therapy: Initial Fears and Expectations Versus Reality 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Narek Shaverdian, (unknown), John V. Hegde, (unknown), Michael L. Steinberg, Susan A. McCloskey	2
16	5-Day Hypofractionated Preoperative Radiation Therapy in Soft Tissue Sarcoma: Preliminary Toxicity and Pathologic Outcomes from a Prospective Phase 2 Study 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Anusha Kalbasi, Mitchell Kamrava, Scott D. Nelson, Sarah Dry, (unknown), Bartosz Chmielowski, Arun S. Singh, Noah Federman, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Fritz C. Eilber	3
17	Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer 2017 ·Urology ·John V. Hegde, Darlene Veruttipong, Jonathan Said, Robert E. Reiter, Michael L. Steinberg, Christopher R. King, Amar U. Kishan	4
18	Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer 2017 ·Clinical Breast Cancer ·John V. Hegde, Xiaoyan Wang, Deanna J. Attai, Maggie L. DiNome, Amy M. Kusske, (unknown), Sara A. Hurvitz, Joanne B. Weidhaas, Michael L. Steinberg, Susan A. McCloskey	6
19	Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 trial 2017 ·Cancer ·John V. Hegde, Narek Shaverdian, Megan E. Daly, Carol Felix, (unknown), Michael H. Rosove, Jordan H. Garst, Pin‐Chieh Wang, Darlene Veruttipong, Shyam Rao, Rubén Fragoso, Jonathan W. Riess, Michael L. Steinberg, Allen M. Chen	24
20	Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma 2013 ·Sarcoma ·(unknown), Michael T. Selch, Pin‐Chieh Wang, Noah Federman, Jay M. Lee, Fritz C. Eilber, Bartosz Chmielowski, Nzhde Agazaryan, Michael L. Steinberg, Percy Lee	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact